189 related articles for article (PubMed ID: 29989273)
1. Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.
Carcao M; Lambert T; Leissinger C; Escuriola-Ettingshausen C; Santagostino E; Aledort L;
Haemophilia; 2018 Nov; 24(6):845-848. PubMed ID: 29989273
[No Abstract] [Full Text] [Related]
2. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
Leissinger CA; Konkle BA; Antunes SV
Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
[TBL] [Abstract][Full Text] [Related]
3. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
Berntorp E
Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
[TBL] [Abstract][Full Text] [Related]
4. Experience with prophylaxis in Sweden.
Nilsson IM
Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
[No Abstract] [Full Text] [Related]
5. New therapies for hemophilia.
Pipe SW
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):650-656. PubMed ID: 27913542
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII/factor IX prophylaxis for severe hemophilia.
Carcao M; Srivastava A
Semin Hematol; 2016 Jan; 53(1):3-9. PubMed ID: 26805901
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society.
Chuansumrit A; Sosothikul D; Natesirinilkul R; Lektrakul Y; Charoonruangrit U;
Haemophilia; 2018 Sep; 24(5):e387-e390. PubMed ID: 30117632
[No Abstract] [Full Text] [Related]
8. Hemophilia A and B.
Shearin-Patterson T; Davidson EJ
JAAPA; 2013 Apr; 26(4):49. PubMed ID: 23610840
[No Abstract] [Full Text] [Related]
9. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
[No Abstract] [Full Text] [Related]
10. The current status of prophylactic replacement therapy in children and adults with haemophilia.
Ljung R; Gretenkort Andersson N
Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
[TBL] [Abstract][Full Text] [Related]
11. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
[TBL] [Abstract][Full Text] [Related]
12. [Management of hemophilia].
Laurian Y
Rev Prat; 1989 Dec; 39(30):2669-73. PubMed ID: 2515580
[TBL] [Abstract][Full Text] [Related]
13. Factor concentrate prophylaxis for neonates with hemophilia.
Buchanan GR
J Pediatr Hematol Oncol; 1999; 21(4):254-6. PubMed ID: 10445886
[No Abstract] [Full Text] [Related]
14. Results of secondary prophylaxis in children with severe hemophilia.
Manco-Johnson MJ; Nuss R; Geraghty S; Funk S; Kilcoyne R
Am J Hematol; 1994 Oct; 47(2):113-7. PubMed ID: 8092125
[TBL] [Abstract][Full Text] [Related]
15. Recombinant clotting factor concentrates.
Lusher JM
Baillieres Clin Haematol; 1996 Jun; 9(2):291-303. PubMed ID: 8800506
[No Abstract] [Full Text] [Related]
16. [Hemophilia, a changed picture].
Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ
Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448
[No Abstract] [Full Text] [Related]
17. Management of joint bleeding in hemophilia.
Simpson ML; Valentino LA
Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic factor replacement in hemophilia.
Carcao MD; Aledort L
Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
[TBL] [Abstract][Full Text] [Related]
19. Current issues in prophylactic therapy for persons with hemophilia.
Dunn AL; Abshire TC
Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis in children with hemophilia: is it the optimal treatment?
Lusher JM
Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
